Presentation is loading. Please wait.

Presentation is loading. Please wait.

Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

Published by Modified over 5 years ago

Similar presentations

Presentation on theme: "Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke."— Presentation transcript:

1 Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer 
Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke Muraoka, Nobuhiko Tanigawa  The Annals of Thoracic Surgery  Volume 65, Issue 5, Pages (May 1998) DOI: /S (97)

2 Fig. 1 Immunohistochemical staining by anti-CD34 antibodies in lung cancer (squamous cell carcinoma). (A) Example of a tumor in the hypervascular group, showing a number of small caliber microvessels. (B) Example of a tumor in the hypovascular group. (Original magnification, ×200; scale bar = 100 μm.) The Annals of Thoracic Surgery  , DOI: ( /S (97) )

3 Fig. 2 Kaplan-Meier survival curves based on the microvessel counts in tumors of patients with non–small cell lung cancer. Survival time is significantly shorter in patients in the hypervascular group than in the hypovascular group (p < ). The Annals of Thoracic Surgery  , DOI: ( /S (97) )

Download ppt "Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke."

Similar presentations

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304  Martin J. Edelman, MD, Lydia.

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB   Martin J. Edelman, MD, Lydia.
Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer  Wu-Wei Lai, MD, Fen-Fen Chen, MD,

Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer  Wu-Wei Lai, MD, Fen-Fen Chen, MD,
Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease  Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease  Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
Tumor angiogenesis in predicting the survival of patients with stage I lung cancer  Baris Medetoglu, MD, Mehmet Zeki Gunluoglu, MD, Adalet Demir, MD, Huseyin.

Tumor angiogenesis in predicting the survival of patients with stage I lung cancer  Baris Medetoglu, MD, Mehmet Zeki Gunluoglu, MD, Adalet Demir, MD, Huseyin.
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Volume 52, Issue 3, Pages (September 2007)

Volume 52, Issue 3, Pages (September 2007)
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,
Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 
Didier Lardinois, MD, Renate Rechsteiner, MD, R

Didier Lardinois, MD, Renate Rechsteiner, MD, R
Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.

Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.
E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro.

E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro.
A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.

A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Clinicopathological and biological assessment of lung cancers with pleural dissemination  Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto.

Clinicopathological and biological assessment of lung cancers with pleural dissemination  Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto.
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Tumor marker expression is predictive of survival in patients with esophageal cancer  Thomas A Aloia, MD, David H Harpole, MD, Carolyn E Reed, MD, Carmen.

Tumor marker expression is predictive of survival in patients with esophageal cancer  Thomas A Aloia, MD, David H Harpole, MD, Carolyn E Reed, MD, Carmen.
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Similar presentations

Ads by Google